Please assess the completion status of the following clinical trial:

Trial Title: Open Versus Endovascular Repair of Popliteal Artery Aneurysm Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age \> 35 years~2. Popliteal artery aneurysm \> 2 cm in diameter with or without presence of mural thrombus~3. Candidate for either OPAR or EPAR as judged by the treating investigator.~4. Greater than 2 cm length of normal superficial femoral artery distal to the deep femoral artery takeoff and \>2 cm length of normal popliteal artery proximal to the first patent tibial artery.~5. Willing to comply with protocol, attend follow-up appointments, complete all study assessments, and provide written informed consent.~Exclusion Criteria:~1. Popliteal artery thrombosis~2. Popliteal artery aneurysm causing symptomatic thromboembolic disease or compressive symptoms.~3. Superficial femoral artery occlusion or distal tibio-peritoneal occlusion~4. Less than 2 cm length of normal artery to accommodate stent graft seal~5. Life expectancy of less than 2 years.~6. Deemed excessive risk for surgical bypass (defined as prohibitive operative risk by formal pre-procedural cardiac risk assessment undertaken by a cardiologist or internist according to established AHA guideline criteria).~7. A documented hypercoagulable state (defined as a known blood disorder associated with venous or arterial thrombosis).~8. Any infrainguinal revascularization procedure on index leg within 12 weeks prior to treatment initiation.~9. Current immune-suppressive medication, chemotherapy or radiation therapy.~10. Absolute contraindication to iodinated contrast due to prior near-fatal anaphylactoid reaction (laryngospasm, bronchospasm, cardiorespiratory collapse, or equivalent) and which would preclude patient from participation in angiographic procedures.~11. Allergy to stainless steel or nitinol.~12. Pregnancy or lactation.~13. Inability or refusal to provide informed consent.~14. Patients who received an investigational drug for peripheral arterial disease within 4 weeks of screening or who participated in another non-observational clinical trial in the prior 30 days.~15. Prior leg bypass on the ipsilateral limb

- Gender: ALL
- Minimum Age: 35 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Open Surgery (Type: ACTIVE_COMPARATOR): In this arm, patients randomized to open surgical repair of popliteal artery aneurysm (OPAR).
- Endovascular Surgical repair (EPAR) (Type: ACTIVE_COMPARATOR): In this arm, patients randomized to endovascular repair of popliteal artery aneurysm (EPAR).

Based on this trial design, predict the completion outcome and termination type (if applicable).